Labcorp

,  /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on September 11, 2026, to stockholders of record as of the close of business on August 28, 2026.

Q2 2026 Labcorp Holdings Inc. Earnings Conference Call

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 , /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on Thursday, July 30, 2026. The company will host a webcast beginning at 9:00 a.m. ET that day to discuss the results.

First FDA-approved, at-home screening test that uses RNA technology to detect biomarkers associated with colorectal cancer and advanced adenomas Designed to reduce common barriers to at-home screening with a cleaner, simplified collection experience that minimizes sample handling Meets screening guidelines from the American Cancer Society (ACS) and National Comprehensive Cancer Network (NCCN) , /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory...

You can download MyLabcorp from the Apple App Store or Google Play Store on your mobile device. Use these steps to get started: Search for “MyLabcorp” Select the app published by  Laboratory Corporation of America Select Download or Install. Then, open the app and follow the on‑screen steps to Sign In or Create an Account. MyLabcorp uses artificial intelligence (AI) to help explain your Labcorp health data. The AI chat can answer questions about your lab results.

Collaboration aims to advance women’s health, support athlete wellbeing and fuel the growth of women’s sports NEW YORK & BURLINGTON, N.C. (June 11, 2026) –The Athletes Unlimited Softball League (AUSL) today announced a new collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, naming Labcorp the Official Consumer Health Testing Partner of the AUSL.

Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members Research will also assess the clinical impact of broader genetic testing in colorectal cancer care , /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced a collaboration with the Alliance for Clinical Trials in Oncology to advance a national, multicenter clinical...

New pharmacogenomic test detects all DPYD variants recommended by the Association for Molecular Pathology to support safer, more personalized cancer treatment , /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the availability of its expanded DPYD Genotyping test to help identify cancer patients who may be at increased risk for severe or life-threatening side effects from fluoropyrimidine chemotherapy.

Laboratory Corporation of America at Jefferies Global Healthcare Conference

, /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will present at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, from 12:15 pm to 12:45 pm ET. The presentation can be accessed via a live webcast on the Labcorp Investor Relations website at ir.labcorp.com.